Machina Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-3,843
| Closed | -$443K | – | 339 |
|
2024
Q3 | $443K | Buy |
3,843
+828
| +27% | +$95.4K | 0.18% | 191 |
|
2024
Q2 | $415K | Sell |
3,015
-254
| -8% | -$35K | 0.19% | 193 |
|
2024
Q1 | $451K | Sell |
3,269
-900
| -22% | -$124K | 0.24% | 162 |
|
2023
Q4 | $549K | Buy |
+4,169
| New | +$549K | 0.35% | 112 |
|
2020
Q1 | – | Sell |
-4,102
| Closed | -$441K | – | 198 |
|
2019
Q4 | $441K | Buy |
4,102
+865
| +27% | +$93K | 0.18% | 207 |
|
2019
Q3 | $292K | Buy |
+3,237
| New | +$292K | 0.13% | 221 |
|